We are live on ! Find out more
Zurich Cantonal Bank

Zurich Cantonal Bank Portfolio holdings

AUM $46B
1-Year Est. Return 27.59%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+27.59%
3 Year Est. Return
+97.89%
5 Year Est. Return
+132.69%
10 Year Est. Return
+500.34%
AUM
$22.7B
AUM Growth
+$2.11B
Cap. Flow
+$540M
Cap. Flow %
2.38%
Top 10 Hldgs %
29.27%
Holding
2,904
New
55
Increased
1,438
Reduced
459
Closed
109

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$61M
2
AAPL icon
Apple
AAPL
+$60.4M
3
GILD icon
Gilead Sciences
GILD
+$45.9M
4
ALC icon
Alcon
ALC
+$43.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$36.6M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$72.5M
2
PFE icon
Pfizer
PFE
+$45.3M
3
EBAY icon
eBay
EBAY
+$37.4M
4
MOS icon
The Mosaic Company
MOS
+$30.5M
5
KEYS icon
Keysight
KEYS
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 27.22%
2 Healthcare 15.42%
3 Financials 14.28%
4 Consumer Discretionary 9.68%
5 Industrials 9.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SKWD icon
2526
Skyward Specialty Insurance
SKWD
$2.51B
$55.3K ﹤0.01%
+2,176
New +$50.3K
DOMO icon
2527
Domo
DOMO
$189M
$55K ﹤0.01%
3,755
CDRE icon
2528
Cadre Holdings
CDRE
$1.4B
$54.9K ﹤0.01%
2,520
BBUC
2529
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$5.9B
$54.9K ﹤0.01%
+2,909
New +$58.3K
BMEA icon
2530
Biomea Fusion
BMEA
$92.1M
$54.9K ﹤0.01%
+2,502
New +$78.3K
BLUE
2531
DELISTED
bluebird bio
BLUE
$54.9K ﹤0.01%
834
-37
-4% -$2.71K
NRIX icon
2532
Nurix Therapeutics
NRIX
$2.69B
$54.8K ﹤0.01%
5,483
HGTY icon
2533
Hagerty
HGTY
$1.34B
$54.7K ﹤0.01%
+5,847
New +$53.9K
ACEL icon
2534
Accel Entertainment
ACEL
$978M
$54.6K ﹤0.01%
5,168
-28,938
-85% -$272K
TSE
2535
DELISTED
Trinseo
TSE
$54.3K ﹤0.01%
4,287
TCOM icon
2536
Trip.com Group
TCOM
$29.7B
$54.1K ﹤0.01%
1,547
-140,356
-99% -$4.88M
NSTG
2537
DELISTED
NanoString Technologies, Inc.
NSTG
$53.9K ﹤0.01%
13,316
RMNI icon
2538
Rimini Street
RMNI
$458M
$53.5K ﹤0.01%
11,170
+9,344
+512% +$38.7K
PGC icon
2539
Peapack-Gladstone Financial
PGC
$800M
$53.5K ﹤0.01%
1,974
CSTL icon
2540
Castle Biosciences
CSTL
$988M
$53.3K ﹤0.01%
3,888
IBRX icon
2541
ImmunityBio
IBRX
$7.94B
$53.3K ﹤0.01%
19,173
EQBK icon
2542
Equity Bancshares
EQBK
$1.04B
$53.2K ﹤0.01%
2,337
GIC icon
2543
Global Industrial
GIC
$1.52B
$52.9K ﹤0.01%
1,904
METC icon
2544
Ramaco Resources Class A
METC
$645M
$52.8K ﹤0.01%
+6,865
New +$57.2K
CTEV
2545
Claritev Corp
CTEV
$581M
$52.7K ﹤0.01%
624
LOVE
2546
LoveSac
LOVE
$253M
$52.6K ﹤0.01%
1,950
WTI icon
2547
W&T Offshore
WTI
$577M
$52.5K ﹤0.01%
13,562
CRMT icon
2548
America's Car Mart
CRMT
$26.1M
$52.2K ﹤0.01%
523
OLP
2549
One Liberty Properties
OLP
$512M
$52.2K ﹤0.01%
2,568
RMAX icon
2550
RE/MAX Holdings
RMAX
$243M
$52.2K ﹤0.01%
2,708

Similar funds

Zurich Cantonal Bank's Q2 2023 Portfolio in Review

As of Q2 2023, Zurich Cantonal Bank held 2,904 positions worth $22.7B, up 10% from $20.5B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Zurich Cantonal Bank's Q2 2023 filing shows 55 new, 1,438 increased, 459 reduced and 109 closed positions. Its largest new stake was monday.com: 5,910 shares worth $1.01M. The largest sale was AbbVie, an estimated $72.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

  • Zurich Cantonal Bank's largest Q2 2023 buy was monday.com: 5,910 shares worth $1.01M.
  • Zurich Cantonal Bank added most to Adobe in Q2 2023, an estimated $61M increase.
  • Zurich Cantonal Bank's biggest Q2 2023 reduction was AbbVie, cutting an estimated $72.5M.
  • Zurich Cantonal Bank fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $17.2M.
  • Zurich Cantonal Bank's ten largest holdings make up 29% of its $22.7B portfolio in Q2 2023.
  • Zurich Cantonal Bank opened 55 new positions and closed 109 in Q2 2023.
  • Zurich Cantonal Bank's portfolio value rose 10% quarter-over-quarter to $22.7B.

Based on Zurich Cantonal Bank's 13F filing for Q2 2023, filed 7 Aug 2023.